Napean Trading & Investment Co Singapore PTE Ltd Buys 19,193 Shares of Danaher Co. (NYSE:DHR)

Napean Trading & Investment Co Singapore PTE Ltd grew its position in shares of Danaher Co. (NYSE:DHR) by 52.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,497 shares of the conglomerate’s stock after buying an additional 19,193 shares during the quarter. Danaher accounts for approximately 3.2% of Napean Trading & Investment Co Singapore PTE Ltd’s holdings, making the stock its 11th largest position. Napean Trading & Investment Co Singapore PTE Ltd’s holdings in Danaher were worth $12,739,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher in the fourth quarter worth about $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher in the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC grew its holdings in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $211.63 on Monday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market capitalization of $151.26 billion, a price-to-earnings ratio of 40.08, a PEG ratio of 2.66 and a beta of 0.82. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The firm’s fifty day simple moving average is $217.46 and its 200-day simple moving average is $238.50.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company earned $2.09 earnings per share. As a group, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on DHR shares. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Jefferies Financial Group decreased their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Five research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $278.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.